Facebook Pixel Code

Concord Biotech Share Price

NSE
BSE

CONCORD BIOTECH

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Concord Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,680.00 Closed
1.46₹ 24.2
As on Sep 19, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Concord Biotech Price Performance

Today's LowToday's High
₹1,656.60₹1,702.10
₹1,680.00
52 Weeks' Low52 Weeks' High
₹1,370.05₹2,658.00
₹1,680.00
Open Price
₹1,656.60
Prev. Close
₹1,655.80
Volume
3,132

Over the last 5 years, the share price of Concord Biotech has gained 12.27% CAGR. Over the past year, the corresponding return has been -25.60%.

Concord Biotech’s current P/E of 49.35x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Concord Biotech Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Concord Biotech
2.76-0.76-8.702.13-35.3021.2812.27
Sun Pharmaceutical Industries
2.461.31-0.48-5.37-11.2323.7226.88
Divi's Laboratories
2.723.09-6.066.3013.5819.5914.40
Cipla
0.101.915.004.12-3.9115.0415.46
Torrent Pharmaceuticals
2.14-0.5614.9512.775.2135.0421.92
Dr. Reddy's Laboratories
0.556.26-0.1411.541.0017.315.19
Mankind Pharma
3.116.1616.2118.434.4323.1613.31
Zydus Lifesciences
-0.755.498.3613.12-1.7442.3221.23
Lupin
0.756.065.71-1.29-4.3847.4814.61
Alkem Laboratories
2.043.0116.3613.37-8.6919.6414.17
Aurobindo Pharma
2.176.922.02-4.77-25.2929.107.17
Abbott India
-1.82-6.80-3.580.737.7420.4713.85
Glenmark Pharmaceuticals
-2.168.4127.3541.0328.2577.8434.53
Laurus Labs
4.196.5843.3454.4999.7422.5226.75
Biocon
1.262.885.158.421.128.42-2.92
Anthem Biosciences
1.981.0516.3616.3616.365.183.08
GlaxoSmithKline Pharmaceuticals
-1.38-1.75-14.62-4.340.9524.7110.06
Ipca Laboratories
6.862.632.360.32-2.0017.896.17
Cohance Lifesciences
-7.401.68-7.76-23.89-25.1725.5119.13
Gland Pharma
0.044.0017.4327.1712.58-3.432.12

Over the last one year, Concord Biotech has declined 35.30% compared to peers like Sun Pharmaceutical Industries (-11.23%), Divi's Laboratories (13.58%), Cipla (-3.91%). From a 5 year perspective, Concord Biotech has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).

Concord Biotech Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Concord Biotech Stock Technicals

Moving Average

DaySMAEMA
51,637.051,643.06
101,638.011,646.23
201,672.331,661.04
501,733.341,703.84
1001,728.081,737.12
2001,834.051,757.29

Concord Biotech Share Holding Pattern

In the latest quarter, Concord Biotech remained same as its previous close in promoter holding, while DII stake decreased to 8.85%, FII holding fell to 9.10%, and public shareholding moved up to 37.94% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Concord Biotech Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
HSBC Small Cap Fund - Regular Plan8,53,9620.9143.61
SBI Healthcare Opportunities Fund7,20,0003.06121.08
DSP Healthcare Fund4,89,7742.6582.37
Invesco India Smallcap Fund3,30,1930.7255.53
Baroda BNP Paribas Balanced Advantage Fund2,80,0001.0947.09
Baroda BNP Paribas Multi Cap Fund2,59,0751.4943.57
Invesco India Multicap Fund2,26,0420.9438.01
Invesco India Flexi Cap Fund1,50,1090.6925.24
Edelweiss Small Cap Fund1,45,5770.524.48
Baroda BNP Paribas Large and Mid Cap Fund1,40,0001.4723.54
View All Mutual Funds

Concord Biotech Corporate Actions

Date Time
Announcement
Sep 11, 2025, 8:48 PM ISTConcord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 11, 2025, 8:44 PM ISTConcord Biotech Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sep 11, 2025, 8:19 PM ISTConcord Biotech Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 09, 2025, 11:23 PM ISTConcord Biotech Ltd. - Shareholder Meeting / Postal Ballot-Outcome of AGM
Aug 21, 2025, 7:43 PM ISTConcord Biotech Ltd. - Successful Completion Of EU GMP Inspection

About Concord Biotech

Concord Biotech Ltd. is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1984PLC007440 and registration number is 007440. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1200.09 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Sudhir Vaid
    Chairman & Managing Director
  • Mr. Ankur Vaid
    Joint Managing Director & CEO
  • Mr. Ravi Kapoor
    Non Executive Director
  • Mr. Rajiv Ambrish Agarwal
    Non Executive Director
  • Mrs. Bharti Khanna
    Independent Director
  • Mr. Amitabh Thakore
    Independent Director
  • Mr. Arvind Agarwal
    Independent Director
  • Mr. Jayaram Easwaran
    Independent Director
  • Mr. Mandayam Chakravarthy Sriraman
    Independent Director

FAQs on Concord Biotech Share Price

What is the share price of Concord Biotech?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Biotech is ₹1,680.00 as on Sep 19, 2025.

What kind of stock is Concord Biotech?

The Concord Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Concord Biotech?

The market cap of Concord Biotech is ₹17,575.52 Cr as on Sep 19, 2025.

What are today's High and Low prices of Concord Biotech?

Today’s highest and lowest price of Concord Biotech are ₹1,702.10 and ₹1,656.60.

What are the 52 Week High and 52 Week Low of Concord Biotech?

The 52-week high/low is the highest and lowest price at which Concord Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Biotech is ₹2,658.00 and 52-week low of Concord Biotech is ₹1,370.05 as on Sep 19, 2025.

How has the Concord Biotech performed historically in terms of returns?

The Concord Biotech has shown returns of 1.46% over the past day, 1.88% for the past month, -14.66% over 3 months, -25.6% over 1 year, 21.28% across 3 years, and 12.27% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Concord Biotech?

P/E ratio of and PB ratio of Concord Biotech are 49.35 and 11.05 on Sep 19, 2025. While the company gives a dividend yield of 0.64 per annum.

icon
Market Data